Ensuring uninterrupted supplies of antiretroviral drugs in resource-poor settings: an example from Malawi

Abstract

Problem Drug procurement and distribution practices are weak in many resource-poor countries, and are a major reason for lack of access to medicines. With many countries scaling up antiretroviral therapy (ART), it is vital to avoid interrupted drug supplies, which would lead to drug resistance and treatment failure. Approach Malawi has adapted a model, based on that adopted by the country's Tuberculosis Control Programme, to allow rational ART drug forecasting. Local setting The model includes a focus on one standardized first-line ART regimen; a "push system" and "ceilings" for first-line ART drugs for facilities; use of starter pack and continuation pack kits; quarterly monitoring of patient outcomes and ART drug stocks at facility level; provision of a three-month buffer stock of ART drugs at facility level; and use of a procurement and distribution system outside central medical stores. Lessons learned The focus on a single first-line regimen, "ceilings" for first-line ART drugs and quarterly data collections to calculate drug needs (for new and follow-up patients, respectively), as well as the use of an independent procurement facility, allow drug orders to be made 6-9 months ahead. These measures have so far ensured that there have been no ART drug stock-outs in the country. Une traduction en français de ce résumé figure à la fin de l'article. Al final del artículo se facilita una traducción al español.

Antiretroviral treatment changes in adults from Côte d'Ivoire: the roles of tuberculosis and pregnancy

“…Furthermore, high rates of nevirapine and efavirenz crossover may hinder drug forecasting at the program level. In sub-Saharan Africa, drug forecasting and stable drug management systems are crucial to ensuring the success of HIV treatment programs [20]; reductions in rates of drug switches could contribute to the success of ART delivery programs.…”

Strengthening health systems through HIV monitoring and evaluation in Sub-Saharan Africa

“…M&E can also generate high-quality data to satisfy accountability requirements [8,18]. Investment in strengthening a national M&E system is important because it will eventually save resources that may otherwise be spent on inefficient programs or overlapping activities supported by different partners [15][16][17].…”

“…M&E is one of the cornerstones of a country's ability to fight a disease; it provides the information needed to make evidence-based decisions for program management and improvement, policy formulation, and advocacy [15][16][17]. M&E can also generate high-quality data to satisfy accountability requirements [8,18].…”

Antiretroviral therapy for HIV prevention: many concerns and challenges, but are there ways forward in sub-Saharan Africa?

“…20,21 Without a robust system in place there will inevitably be drug and commodity ruptures as ART procurement and distribution will be dramatically increased from thousands to millions. There is also the issue of ensuring and monitoring drug adherence in individuals who generally feel well.…”